315 assets in Malignant Pancreatic Neoplasm

Therapeutic assets addressing Malignant Pancreatic Neoplasm, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Fapi-46 Malignant Pancreatic Neoplasm	Barbara Malene Fischer	P2	CCC (53)
Glipizide Malignant Pancreatic Neoplasm	Memorial Sloan Kettering Cancer Center	P2	CCC (53)
Human Adenovirus C Serotype 5 Malignant Pancreatic Neoplasm	Thomas Jefferson University	P2	CCC (53)
ibi343 Malignant Pancreatic Neoplasm	Zhejiang University	P2	CCC (53)
Immunoglobulin G1, Anti-(Human 5'-Nucleotidase) (Human Monoclonal Medi9447 Heavy Chain), Disulfide With Human Monoclonal Medi9447 .Lambda.-Chain, Dimer Malignant Pancreatic Neoplasm	M.D. Anderson Cancer Center	P2	CCC (53)
Immunoglobulin G1 [De-C-Terminal-Lysine], Anti-(Human Cc Chemokine Receptor Ccr8) (Human-Mus Musculus Monoclonal Bms-986340 ?1-Chain), Disulfide With Human-Mus Musculus Monoclonal Bms-986340 ?-Chain, Dimer Malignant Pancreatic Neoplasm	Mayo Clinic	P2	CCC (53)
Mitoxantrone Malignant Pancreatic Neoplasm	CSPC ZhongQi Pharmaceutical Technology Co., Ltd.	P2	CCC (53)
Nlm-001 Malignant Pancreatic Neoplasm	Nelum Corp	P2	CCC (53)
Osimertinib Malignant Pancreatic Neoplasm	OHSU Knight Cancer Institute	P2	CCC (53)
Pegteograstim Malignant Pancreatic Neoplasm	Yonsei University	P2	CCC (53)
Pimicotinib Malignant Pancreatic Neoplasm	Abbisko Therapeutics Co, Ltd	P2	CCC (53)
Recombinant Human Il-21-Expressing Oncolytic Vaccinia Virus Malignant Pancreatic Neoplasm	Hangzhou Converd Co., Ltd.	P2	CCC (53)
Recombinant Interleukin-12 Malignant Pancreatic Neoplasm	Zhejiang University	P1/2	CCC (53)
Tamoxifen Malignant Pancreatic Neoplasm	OHSU Knight Cancer Institute	P2	CCC (53)
Tripegfilgrastim Malignant Pancreatic Neoplasm	National Cancer Center, Korea	P2	CCC (53)
Zoledronate Malignant Pancreatic Neoplasm	University of Nebraska	P2	CCC (53)
[68ga]cbp8 Malignant Pancreatic Neoplasm	Massachusetts General Hospital	P2	CCC (51)
Anamorelin Malignant Pancreatic Neoplasm	Lahey Clinic	P2	CCC (51)
Benzamide, 3-((3-Endo)-8-(2-((Cyclohexylmethyl)((2S)-2,3-Dihydroxy-1-Oxopropyl)Amino)Ethyl)-8-Azabicyclo(3.2.1)Oct-3-Yl)- Malignant Pancreatic Neoplasm	HealthPartners Institute	P2	CCC (51)
Cdx 1140 Malignant Pancreatic Neoplasm	Washington University School of Medicine	P2	CCC (51)
Certepetide Malignant Pancreatic Neoplasm	Lisata Therapeutics, Inc.	P2	CCC (51)
Devimistat Malignant Pancreatic Neoplasm	Northwestern University	P2	CCC (51)
Donafenib Malignant Pancreatic Neoplasm	Fudan University	P2	CCC (51)
Enfortumab Vedotin (Fully Human Monoclonal Antibody Conjugated To A Cytotoxic Agent Monomethyl Auristatin E (Mmae) Targeting Nectin-4) Malignant Pancreatic Neoplasm	University of Kansas Medical Center	P2	CCC (51)
Glubran 2 Malignant Pancreatic Neoplasm	Minia University	P2	CCC (51)
Lomustine Malignant Pancreatic Neoplasm	Actuate Therapeutics Inc.	P2	CCC (51)
ltc004 Malignant Pancreatic Neoplasm	Cancer Institute and Hospital, Chinese Academy of Medical Sciences	P2	CCC (51)
Mirabegron Malignant Pancreatic Neoplasm	Zhejiang Provincial People's Hospital	P2	CCC (51)
Pantoprazole Malignant Pancreatic Neoplasm	Washington University School of Medicine	P2	CCC (51)
Pemigatinib Malignant Pancreatic Neoplasm	Sameek Roychowdhury	P2	CCC (51)
Rain-32 Malignant Pancreatic Neoplasm	Rain Oncology Inc	P2	CCC (51)
Rivoceranib Malignant Pancreatic Neoplasm	Shandong Provincial Hospital	P2	CCC (51)
Salmonella-Il2 Malignant Pancreatic Neoplasm	Salspera LLC	P2	CCC (51)
Sgt-53 Malignant Pancreatic Neoplasm	SynerGene Therapeutics, Inc.	P2	CCC (51)
Tucidinostat Malignant Pancreatic Neoplasm	Tianjin Medical University Cancer Institute and Hospital	P2	CCC (51)
Young Til Malignant Pancreatic Neoplasm	National Cancer Institute (NCI)	P2	CCC (51)
Zolbetuximab Malignant Pancreatic Neoplasm	Astellas Pharma Global Development, Inc.	P2	CCC (51)
Bemcentinib Malignant Pancreatic Neoplasm	BerGenBio ASA	P1/2	CCC (50)
Simvastatin Malignant Pancreatic Neoplasm	State University of New York - Downstate Medical Center	P1/2	CCC (50)
TIL Malignant Pancreatic Neoplasm	City of Hope Medical Center	P1	CCC (50)
Elraglusib Malignant Pancreatic Neoplasm	Actuate Therapeutics Inc.	P2	CCC (49)
Galeterone Malignant Pancreatic Neoplasm	University of Maryland, Baltimore	P2	CCC (49)
Avotaciclib Malignant Pancreatic Neoplasm	BeyondBio Inc.	P1/2	CCC (48)
Cea-Targeted Car-T Malignant Pancreatic Neoplasm	Chongqing Precision Biotech Co., Ltd	P1/2	CCC (48)
Edv-Gc Malignant Pancreatic Neoplasm	Engeneic Pty Limited	P1/2	CCC (48)
E-Edv-D682 Malignant Pancreatic Neoplasm	Engeneic Pty Limited	P1/2	CCC (48)
Erfonrilimab Malignant Pancreatic Neoplasm	Shanghai Zhongshan Hospital	P1/2	CCC (48)
Intratumoral Mmr Malignant Pancreatic Neoplasm	University of Arkansas	P1/2	CCC (48)
Samuraciclib Malignant Pancreatic Neoplasm	University Health Network, Toronto	P1/2	CCC (48)
Tipiracil Malignant Pancreatic Neoplasm	Emory University	P1/2	CCC (48)

Showing 101 to 150 of 315 assets

PreviousPage 3 of 7Next